Safety of Administering Isoniazid to SLE Patients to Prevent TB

NCT06618573 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis
Systemic Lupus Erythematosus

Interventions

DRUG: Isoniazid/Pyridoxine
DRUG: Saccharum Lactis

Sponsor

Universitas Padjadjaran